López Del Amo, Víctor http://orcid.org/0000-0002-5567-3072
Bishop, Alena L. http://orcid.org/0000-0001-7189-015X
Sánchez C., Héctor M. http://orcid.org/0000-0001-7378-8853
Bennett, Jared B.
Feng, Xuechun http://orcid.org/0000-0003-4313-700X
Marshall, John M. http://orcid.org/0000-0003-0603-7341
Bier, Ethan
Gantz, Valentino M. http://orcid.org/0000-0003-2453-0711
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | NIH Office of the Director (DP5OD023098, DP5OD023098, DP5OD023098, DP5OD023098)
U.S. Department of Health & Human Services | NIH | NIH Office of the Director
United States Department of Defense | Defense Advanced Research Projects Agency (HR0011-17-2-0047, HR0011-17-2-0047)
U.S. Department of Health & Human Services | NIH | NIH Office of the Director
U.S. Department of Health & Human Services | NIH | NIH Office of the Director
Article History
Received: 3 July 2019
Accepted: 11 December 2019
First Online: 17 January 2020
Competing interests
: V.M.G. and E.B. have equity interests in Synbal, Inc. and Agragene, Inc., companies that may potentially benefit from the research results and also serve on the company’s Scientific Advisory Board and Board of Directors. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. V.L.D.A., A.L.B., X.F., H.M.S.C., J.B. and J.M.M. declare no competing interests.